Ottobock targets valuation of up to €4.2 billion in Frankfurt IPO
PositiveFinancial Markets

Ottobock, a leading medical technology company, is aiming for a valuation of up to €4.2 billion in its upcoming IPO in Frankfurt. This move is significant as it highlights the company's growth potential and the increasing investor interest in the healthcare sector, especially in innovative solutions for mobility and rehabilitation. A successful IPO could provide Ottobock with the necessary capital to expand its operations and enhance its product offerings.
— Curated by the World Pulse Now AI Editorial System